Detalhe da pesquisa
1.
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Lancet Oncol
; 17(11): 1533-1542, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27686943
2.
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Lancet Oncol
; 17(11): 1521-1532, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27686946